Public research preview

Roger Williams, Representative disclosure: Sunshine Biopharma Inc. - Common stock (SBFM)

Disclosed a buy transaction in Sunshine Biopharma Inc. - Common stock (SBFM). Use this page to inspect source evidence, confidence scores, filing delay, and post-disclosure price movement before deciding whether to research the signal further.

Copy Window
Probably too late
24/100
Signal Quality
63/100
Data quality
93%
High quality

This public page is for public-disclosure research only. It is not investment advice and does not place orders. Verify the official source before relying on any signal.

Evidence passport

Official-source context and parser confidence before any simulation or alert decision.

Source
House STOCK Act disclosures
Published
12 Jun 2024, 00:00
Parser confidence
94%
Instrument mapping
95%
Filing delay
713 days

Timeline

Transaction date

30 Jun 2022

Public disclosure

12 Jun 2024

Now

Tracked today

Filing delay: 713 days

Price movement

Complete coverage

Provider
Yahoo Finance daily close
Fetched
9 Sept 2026

The pre-disclosure spike has collapsed -99.8% from its peak. Retraces deeper than 20% behaved like falling knives in the backtests, not discounts, and are excluded from the discount-entry sleeve.

Stock path

SBFM from pre-transaction context through latest close.

Bought

30 Jun 2022 · 21,600 USD · Not public yet

System decision

Would not buyThe strategy's filters reject this signal. Failed filters: Filed within 30 days.

Not public yetWould not buy1.196,500.6193,000USDDate15 Feb30 Jun12 Jun8 SeptOfficial disclosure12 JunBoughtDisclosureLatest
  • Not public yet
  • Would not buy
Observed transaction close
21,600
Observed disclosure close
57
Observed latest close
1.15
Pre-disclosure move
-99.7%
Post-disclosure move
-98.0%
Market-adjusted move
-120.4%
1w since disclosure
+21.1%
1m since disclosure
+16.1%
3m since disclosure
-50.2%
Pre-disclosure peak run-up
+25.9%
Retrace from peak
-99.8%

Why Copy Window is Probably too late

Supporting factors

  • Parsed buy disclosure for ordinary shares from House STOCK Act disclosures.
  • Reported amount is $1,001 - $15,000.
  • Post-disclosure move is calculated from Yahoo Finance daily close daily closes.

Cautions

  • Yahoo Finance daily close coverage is end-of-day and should be verified against the official price source.
  • Review the original source document before making any investment decision.

Source document

House STOCK Act disclosures, published 12 Jun 2024, 00:00

View source
Parser confidence
94%
Instrument mapping
95%
FieldExtracted value
roleRepresentative
sidebuy
value1001
sourcehouse_stock_act
tickerSBFM
chamberHouse
currencyUSD
assetTypestock
sourceUrlhttps://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2024/20025151.pdf
personNameRoger Williams
amountRange$1,001 - $15,000
companyNameSunshine Biopharma Inc. - Common stock (SBFM)
publishedAt2024-06-12T00:00:00.000Z
rawDocumentIdraw-us-house-20025151-12
disclosureDate2024-06-12
transactionDate2022-06-30
transactionTypeP